NEW DRUGS FOR THE TREATMENT OF CANCER
PharmaEngine
We Race With You
DISCOVER MORE
CANCER TREATMENT PRODUCTS
ONIVYDE
A Revolutionary Durg
DISCOVER ONIVYDE
History<br> &<br> Milestones<br>
History
&
Milestones
Onivyde
Onivyde

PharmaEngine announces first patient dosed in Phase I trial of PEP07 for hematological cancers

PharmaEngine announces EMA’s acceptance of ONIVYDE®’s Type II Variation application

PharmaEngine files post-approval change application for a new indication of ONIVYDE® to TFDA
PEP07
R&D Pipeline
Events & Presentations
Organization
Our Partners
Contact Us
© 2020 PharmaEngine Inc.
Go To Top